honokiol has been researched along with Lymph Node Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, Y; Pan, J; Wan, TC; Wang, Y; Xiong, D; You, M; Zhang, Q | 1 |
| Chen, LJ; Chen, P; Chen, XC; Fu, AF; Li, J; Lu, Y; Shao, XM; Tang, MH; Wang, YS; Wei, YQ; Wen, J; Xie, XJ; Yang, GL; Zhao, X | 1 |
2 other study(ies) available for honokiol and Lymph Node Metastasis
| Article | Year |
|---|---|
Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Lignans; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred NOD; Mice, SCID; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Lewis Lung; Cell Line; Endothelial Cells; Female; Humans; Lignans; Liposomes; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Vascular Endothelial Growth Factor D; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays | 2009 |